Over the past 12 months, 6 insiders at Oruka Therapeutics, Inc. filed 53 open-market SEC Form 4 transactions on ORKA: 0 purchases worth $0 and 53 sales worth $14.6M. Insiders have been net sellers over this period. The most recent filing was on Jul 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 26 | Joana GoncalvesChief Medical Officer | SELL | 3.8K | $87.25 | $330K |
| Jul 13, 26 | Arjun AgarwalSenior Vice President, Finance | SELL | 5.7K | $84.90 | $480K |
| Jun 22, 26 | Arjun AgarwalSenior Vice President, Finance | SELL | 888 | $82.14 | $71K |
| Jun 15, 26 | Arjun AgarwalSenior Vice President, Finance | SELL | 395 | $69.69 | $28K |
| Jun 15, 26 | Joana GoncalvesChief Medical Officer | SELL | 5.1K | $70.62 | $352K |
| Jun 12, 26 | Arjun AgarwalSenior Vice President, Finance | SELL | 4.3K | $70.34 | $303K |
| Jun 12, 26 | Carl Dambkowski | SELL | 12.6K | $70.11 | $882K |
| Jun 11, 26 | Carl Dambkowski | SELL | 22.4K | $70.13 | $1.6M |
| May 21, 26 | Carl Dambkowski | SELL | 53.4K | $59.97 | $3.2M |
| May 18, 26 | Arjun AgarwalSenior Vice President, Finance | SELL | 4.6K | $61.16 | $272K |
| May 15, 26 | Joana GoncalvesChief Medical Officer | SELL | 4.8K | $63.52 | $295K |
| Apr 15, 26 | Joana GoncalvesChief Medical Officer | SELL | 4.2K | $67.38 | $278K |
| Mar 16, 26 | Arjun AgarwalSenior Vice President, Finance | SELL | 395 | $41.30 | $16K |
| Mar 16, 26 | Joana GoncalvesChief Medical Officer | SELL | 2.9K | $41.94 | $120K |
| Mar 16, 26 | Lawrence Otto KleinChief Executive Officer | SELL | 1.7K | $41.30 | $71K |
| Mar 16, 26 | Paul T QuinlanGeneral Counsel | SELL | 733 | $41.30 | $30K |
| Mar 16, 26 | Laura Lee SandlerChief Operating Officer | SELL | 600 | $41.30 | $25K |
| Mar 2, 26 | Laura Lee SandlerChief Operating Officer | SELL | 2.7K | $33.81 | $90K |
| Feb 17, 26 | Joana GoncalvesChief Medical Officer | SELL | 6.1K | $32.78 | $196K |
| Jan 15, 26 | Joana GoncalvesChief Medical Officer | SELL | 4.4K | $32.24 | $138K |
| Jan 2, 26 | Laura Lee SandlerChief Operating Officer | SELL | 8.7K | $29.75 | $246K |
| Dec 19, 25 | Joana GoncalvesChief Medical Officer | SELL | 3.1K | $31.58 | $97K |
| Feb 14, 25 | Vhcp Management Iii, LlcTenPercentOwner | BUY | 88.8K | $11.44 | $1.0M |
| Feb 13, 25 | Vhcp Management Iii, LlcTenPercentOwner | BUY | 14.9K | $11.63 | $174K |
| Feb 12, 25 | Vhcp Management Iii, LlcTenPercentOwner | BUY | 9.0K | $11.86 | $106K |
| Feb 11, 25 | Vhcp Management Iii, LlcTenPercentOwner | BUY | 9.6K | $10.95 | $105K |
| Feb 10, 25 | Vhcp Management Iii, LlcTenPercentOwner | BUY | 574 | $10.90 | $6K |
Over the past 12 months, insiders at Oruka Therapeutics, Inc. filed 0 open-market purchases worth $0 and 53 sales worth $14.6M on ORKA, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 15, 26.
The largest recent open-market ORKA insider purchase in our data was $1.0M by Vhcp Management Iii, Llc, TenPercentOwner, filed on Feb 14, 25.
6 different insiders at Oruka Therapeutics, Inc. filed open-market SEC Form 4 transactions on ORKA over the last 12 months.
InsiderTape plots every ORKA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Oruka Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →